KOBAYASHI PHARMACEUTICAL CO., LTD. Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 5.543 JPY | -0,66% |
|
+0,71% | -18,37% |
| 31/03 | Een tweede fabriek van Kobayashi Pharma Japan geïnspecteerd vanwege sterfgevallen | RE |
| 30/03 | Kobayashi fabriek doorzocht vanwege sterfgevallen die mogelijk verband houden met supplementen | RE |
Totale waarde
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 724.573 | 985.637 | 704.427 | 650.295 | 503.841 | 411.310 | - | - |
| Bedrijfswaarde 1 | 634.907 | 891.987 | 596.011 | 546.554 | 424.992 | 325.271 | 317.784 | 311.680 |
| K/w-verhouding | 38 x | 51,3 x | 35,8 x | 34,8 x | 25,3 x | 19,4 x | 18,7 x | 18,3 x |
| Dividendrendement | 0,79% | 0,61% | 0,92% | 1% | 1,49% | 1,86% | 1,89% | 1,94% |
| Marktkapitalisatie/omzet | 4,31 x | 6,55 x | 4,54 x | 3,91 x | 2,9 x | 2,22 x | 2,13 x | 2,04 x |
| Bedrijfswaarde/omzet | 3,78 x | 5,93 x | 3,84 x | 3,29 x | 2,45 x | 1,75 x | 1,65 x | 1,55 x |
| Bedrijfswaarde/EBITDA | 20,8 x | 29,7 x | 19,3 x | 17,1 x | 13,3 x | 9,37 x | 8,44 x | 7,94 x |
| Bedrijfswaarde/FCF | 45,3 x | 101 x | 31,8 x | 31,1 x | -350 x | 23,5 x | 22 x | 15,2 x |
| FCF Yield | 2,21% | 0,99% | 3,15% | 3,22% | -0,29% | 4,25% | 4,54% | 6,6% |
| Price to Book | 4,2 x | 5,4 x | 3,59 x | 3,47 x | 2,47 x | 1,81 x | 1,7 x | 1,61 x |
| Aantal aandelen (in duizenden) | 78.163 | 78.163 | 77.923 | 72.015 | 74.203 | 74.203 | - | - |
| Referentieprijs 2 | 9.270 | 12.610 | 9.040 | 9.030 | 6.790 | 5.543 | 5.543 | 5.543 |
| Datum van publicatie | 31-01-20 | 01-02-21 | 04-02-22 | 14-02-23 | 09-02-24 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 168.052 | 150.514 | 155.252 | 166.258 | 173.455 | 185.344 | 193.089 | 201.200 |
| EBITDA 1 | 30.482 | 30.049 | 30.900 | 32.027 | 31.837 | 34.696 | 37.670 | 39.259 |
| Bedrijfsresultaat (EBIT) 1 | 26.355 | 25.943 | 26.065 | 26.669 | 25.780 | 27.759 | 28.517 | 29.432 |
| Operationele Marge | 15,68% | 17,24% | 16,79% | 16,04% | 14,86% | 14,98% | 14,77% | 14,63% |
| Resultaat voor belastingen (EBT) 1 | 26.804 | 26.635 | 27.636 | 27.950 | 27.559 | 30.190 | 30.907 | 31.673 |
| Nettowinst (verlies) 1 | 19.139 | 19.205 | 19.715 | 20.022 | 20.338 | 21.360 | 22.032 | 22.634 |
| Nettomarge | 11,39% | 12,76% | 12,7% | 12,04% | 11,73% | 11,52% | 11,41% | 11,25% |
| WPA 2 | 244,1 | 245,7 | 252,4 | 259,6 | 268,2 | 286,0 | 295,9 | 302,9 |
| Free Cash Flow 1 | 14.016 | 8.870 | 18.756 | 17.601 | -1.216 | 13.822 | 14.430 | 20.560 |
| FCF-marge | 8,34% | 5,89% | 12,08% | 10,59% | -0,7% | 7,46% | 7,47% | 10,22% |
| Kasstroomconversie (ebitda) | 45,98% | 29,52% | 60,7% | 54,96% | - | 39,84% | 38,31% | 52,37% |
| Kasstroomconversie (nettowinst) | 73,23% | 46,19% | 95,14% | 87,91% | - | 64,71% | 65,5% | 90,84% |
| Dividend per aandeel 2 | 73,00 | 77,00 | 83,00 | 90,00 | 101,0 | 103,0 | 104,8 | 107,4 |
| Datum van publicatie | 31-01-20 | 01-02-21 | 04-02-22 | 14-02-23 | 09-02-24 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: december | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 94.422 | 66.180 | 84.334 | 67.052 | 40.606 | 47.594 | 88.200 | 32.646 | 38.618 | 71.264 | 43.015 | 51.979 | 94.994 | 33.467 | 40.158 | 73.625 | 45.490 | 54.340 | 99.830 | 36.488 | 42.518 | 77.200 | 48.204 | 58.828 | 105.800 |
| EBITDA 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.710 | 6.380 | - | 9.720 | 8.040 | - |
| Bedrijfsresultaat (EBIT) 1 | 14.934 | 10.220 | 15.723 | 10.240 | 9.186 | 6.639 | 15.825 | 4.845 | 5.023 | 9.868 | 8.881 | 7.920 | 16.801 | 5.061 | 5.345 | 10.406 | 8.981 | 6.393 | 15.374 | 5.705 | 5.790 | 10.900 | 9.410 | 7.420 | 15.900 |
| Operationele Marge | 15,82% | 15,44% | 18,64% | 15,27% | 22,62% | 13,95% | 17,94% | 14,84% | 13,01% | 13,85% | 20,65% | 15,24% | 17,69% | 15,12% | 13,31% | 14,13% | 19,74% | 11,76% | 15,4% | 15,64% | 13,62% | 14,12% | 19,52% | 12,61% | 15,03% |
| Resultaat voor belastingen (EBT) | - | 10.882 | - | 11.037 | 9.855 | - | - | 5.097 | - | 10.860 | 9.510 | 7.580 | - | 5.097 | 5.968 | 11.065 | 10.073 | - | - | - | - | - | - | - | - |
| Nettowinst (verlies) | 10.937 | 8.218 | - | 7.881 | 7.002 | 4.832 | 11.834 | 3.473 | 4.227 | 7.700 | 6.800 | 5.522 | - | 3.608 | 4.256 | 7.864 | 7.634 | 4.840 | - | - | - | - | - | - | - |
| Nettomarge | 11,58% | 12,42% | - | 11,75% | 17,24% | 10,15% | 13,42% | 10,64% | 10,95% | 10,8% | 15,81% | 10,62% | - | 10,78% | 10,6% | 10,68% | 16,78% | 8,91% | - | - | - | - | - | - | - |
| WPA | - | 105,1 | - | 100,8 | 89,58 | 61,94 | - | 44,87 | 54,68 | 99,55 | 87,97 | 72,11 | - | 47,43 | 55,92 | 103,4 | 100,3 | 64,52 | - | - | - | - | - | - | - |
| Dividend per aandeel | - | 34,00 | - | 37,00 | - | 46,00 | - | - | 38,00 | 38,00 | - | 52,00 | - | - | 43,00 | 43,00 | - | 58,00 | - | - | - | - | - | - | - |
| Datum van publicatie | 31-01-20 | 30-07-20 | 01-02-21 | 29-07-21 | 28-10-21 | 04-02-22 | 04-02-22 | 27-04-22 | 03-08-22 | 03-08-22 | 01-11-22 | 14-02-23 | 14-02-23 | 10-05-23 | 08-08-23 | 08-08-23 | 07-11-23 | 09-02-24 | 09-02-24 | - | - | - | - | - | - |
1JPY in Miljoen
Geschatte gegevens
Balans
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | - | - | - | - | - | - | - |
| Nettokaspositie 1 | 89.666 | 93.650 | 108.416 | 103.741 | 78.849 | 86.038 | 93.526 | 99.630 |
| Hefboom (schuld/ebitda) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 14.016 | 8.870 | 18.756 | 17.601 | -1.216 | 13.822 | 14.430 | 20.560 |
| ROE (netto-inkomsten/eigen vermogen) | 11,3% | 10,8% | 10,4% | 10,2% | 10,1% | 10,2% | 9,95% | 9,7% |
| ROA (netto-inkomsten/totale activa) | 12% | 11,8% | 11,4% | 11,1% | 10,4% | 6,3% | 6,07% | 6,03% |
| Totale activa 1 | 159.562 | 163.389 | 172.738 | 179.958 | 194.711 | 339.043 | 363.171 | 375.155 |
| Nettoactief per aandeel 2 | 2.209 | 2.336 | 2.516 | 2.600 | 2.749 | 3.063 | 3.252 | 3.436 |
| Cashflow per aandeel 2 | 292,0 | 295,0 | 303,0 | 316,0 | 333,0 | 388,0 | 434,0 | 452,0 |
| Capex 1 | 6.073 | 15.116 | 5.278 | 15.794 | 26.887 | 12.720 | 13.680 | 9.200 |
| Capex/omzet | 3,61% | 10,04% | 3,4% | 9,5% | 15,5% | 6,86% | 7,08% | 4,57% |
| Datum van publicatie | 31-01-20 | 01-02-21 | 04-02-22 | 14-02-23 | 09-02-24 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
C+
Verkoop
Koop
Gemiddeld advies
Accumuleren
Aantal analisten
6
Laatste slotkoers
5.543
JPY
Gemiddelde koersdoel
8.182
JPY
Spread / Gemiddelde doel
+47,60%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| -18,37% | 2,61 mld. | |
| +10,07% | 381 mld. | |
| +14,18% | 74,67 mld. | |
| -16,59% | 62,59 mld. | |
| +0,82% | 52,86 mld. | |
| -12,40% | 36,11 mld. | |
| +3,54% | 33,57 mld. | |
| +7,92% | 17,29 mld. | |
| +6,30% | 14,75 mld. | |
| -8,65% | 10,82 mld. |
- Beurs
- Aandelen
- Koers 4967
- Financiën Kobayashi Pharmaceutical Co., Ltd.
